Concentra Group Holdings Parent, Inc. Files S-1/A Amendment
Ticker: CON · Form: S-1/A · Filed: Jul 15, 2024 · CIK: 2014596
Sentiment: neutral
Topics: ipo, registration, healthcare
TL;DR
Concentra Group Holdings Parent, Inc. filed an S-1/A amendment on 7/15/24. IPO incoming?
AI Summary
Concentra Group Holdings Parent, Inc. filed an S-1/A amendment on July 15, 2024, for its registration statement. The company, incorporated in Delaware, operates under SIC code 8093 (Specialty Outpatient Facilities, NEC) and is associated with Select Medical Corporation. The filing details its principal executive offices located at 4714 Gettysburg Road, Mechanicsburg, PA.
Why It Matters
This S-1/A filing indicates Concentra Group Holdings Parent, Inc. is moving forward with its public offering plans, which could impact its valuation and market presence.
Risk Assessment
Risk Level: medium — As an S-1/A filing, it represents a company preparing for an IPO, which inherently carries market and execution risks.
Key Numbers
- 333-280242 — SEC File Number (Identifies the specific registration filing)
- 8093 — SIC Code (Industry classification for Specialty Outpatient Facilities)
Key Players & Entities
- Concentra Group Holdings Parent, Inc. (company) — Registrant
- Select Medical Corporation (company) — Associated company
- July 15, 2024 (date) — Filing date
- 8093 (number) — SIC Code
- 333-280242 (number) — SEC File Number
- Michael E. Tarvin (person) — Contact person
FAQ
What is the purpose of this S-1/A filing?
This is an amendment to a previously filed Form S-1 registration statement, indicating updates or revisions to the initial public offering details for Concentra Group Holdings Parent, Inc.
When was this amendment filed?
The amendment was filed on July 15, 2024.
What is Concentra Group Holdings Parent, Inc.'s primary business classification?
The company's primary Standard Industrial Classification (SIC) code is 8093, which corresponds to Specialty Outpatient Facilities, NEC.
Where are Concentra Group Holdings Parent, Inc.'s principal executive offices located?
The principal executive offices are located at 4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055.
Is Concentra Group Holdings Parent, Inc. directly affiliated with Select Medical Corporation?
The filing lists the business and mail address as 'C/O SELECT MEDICAL CORPORATION', suggesting a close operational or administrative relationship.
Filing Stats: 4,381 words · 18 min read · ~15 pages · Grade level 15.2 · Accepted 2024-07-15 06:30:51
Key Financial Figures
- $23.00 — nitial public offering price is between $23.00 and $26.00 per share of our common stoc
- $26.00 — ic offering price is between $23.00 and $26.00 per share of our common stock. Prior to
- $470.0 million — roceeds from this offering to repay (i) $470.0 million of the intercompany note held by SMC an
- $43.6 million — intercompany note held by SMC and (ii) $43.6 million of the principal amount of a promissory
Filing Documents
- tm248173-10_s1a.htm (S-1/A) — 4418KB
- tm248173d11_ex1-1.htm (EX-1.1) — 273KB
- tm248173d11_ex3-1.htm (EX-3.1) — 55KB
- tm248173d11_ex3-2.htm (EX-3.2) — 212KB
- tm248173d11_ex4-1.htm (EX-4.1) — 893KB
- tm248173d11_ex5-1.htm (EX-5.1) — 9KB
- tm248173d11_ex10-2.htm (EX-10.2) — 181KB
- tm248173d11_ex10-6.htm (EX-10.6) — 139KB
- tm248173d11_ex10-7.htm (EX-10.7) — 105KB
- tm248173d11_ex10-8.htm (EX-10.8) — 74KB
- tm248173d11_ex10-9.htm (EX-10.9) — 72KB
- tm248173d11_ex10-10.htm (EX-10.10) — 71KB
- tm248173d11_ex10-11.htm (EX-10.11) — 32KB
- tm248173d11_ex21-1.htm (EX-21.1) — 8KB
- tm248173d11_ex23-1.htm (EX-23.1) — 2KB
- tm248173d11_ex-filingfees.htm (EX-FILING FEES) — 18KB
- lg_concentra-4clr.jpg (GRAPHIC) — 14KB
- cv_ofc-4clr.jpg (GRAPHIC) — 476KB
- mp_health-4clr.jpg (GRAPHIC) — 82KB
- bc_usemployment-4c.jpg (GRAPHIC) — 33KB
- bc_patient-4c.jpg (GRAPHIC) — 19KB
- tb_track-4clr.jpg (GRAPHIC) — 56KB
- bc_confidential-4c.jpg (GRAPHIC) — 24KB
- ph_healthcenters-4clr.jpg (GRAPHIC) — 13KB
- ph_healthclinics-4clr.jpg (GRAPHIC) — 10KB
- ph_otherbusiness-4clr.jpg (GRAPHIC) — 11KB
- tb_support-4c.jpg (GRAPHIC) — 69KB
- tm248173d11_ex5-1img001.jpg (GRAPHIC) — 5KB
- tm248173d11_ex10-11img002.jpg (GRAPHIC) — 3KB
- 0001104659-24-079667.txt ( ) — 7686KB
Risk Factors
Risk Factors 25 Cautionary Note Regarding Forward-Looking Statements 59 Market and Industry Data 61
Use of Proceeds
Use of Proceeds 62 Dividend Policy 63 Capitalization 64
Dilution
Dilution 66 The Separation and Distribution Transactions 68 Unaudited Pro Forma Consolidated Financial Information 71
Management's Discussion And Analysis Of Financial Condition and Results Of Operations
Management's Discussion And Analysis Of Financial Condition and Results Of Operations 78
Business
Business 97 Management 135 Executive and Director Compensation 143 Principal Stockholder 163 Certain Relationships and Related Person Transactions 164
Description of Capital Stock
Description of Capital Stock 170 Description of Certain Indebtedness 175 Shares Eligible for Future Sale 177 Material U.S. Federal Income Tax Considerations for Non-U.S. Holders of Our Common Stock 179
Underwriting
Underwriting 183 Legal Matters 192 Experts 193 Where You Can Find More Information 194 Index to Consolidated Financial Statements F-1 Neither we nor any of the underwriters have authorized anyone to provide any information or to make any representations other than those contained in this prospectus, any amendment or supplement to this prospectus or any free writing prospectus prepared by us or on our behalf. We and the underwriters take no responsibility for, and cannot assure you as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of our common stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of shares of our common stock. Our business, results of operations or financial condition may have changed since that date. For investors outside the United States: Neither we nor any of the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of our common stock and the distribution of this prospectus outside the United States. i TABLE OF CONTENTS ABOUT THIS PROSPECTUS In connection with this offering, we will issue common stock representing not more than 19.91% of our common stock outstanding, with SMC maintaining ownership of at least 80.09% of our common stock (the "Separation"). Select Medical Holdings Corporation ("Select") has informed us that, following the completion of this offering, it intends to make a tax-free distributi